Novo Nordisk is seeking $830 million in damages from KBP Biosciences and its founder over alleged fraudulent claims about ocedurenone. #nephsky #nephrology #kidneydisease #hypertension #drugdevelopment
Comments
Log in with your Bluesky account to leave a comment
Comments